Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of patient-derived xenograft models of prostate cancer for maintaining tumor heterogeneity
Changhong Shi, Xue Chen, Dengxu Tan
Translational Andrology and Urology (2019) Vol. 8, Iss. 5, pp. 519-528
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
Christiana M. Neophytou, Myrofora Panagi, Triantafyllos Stylianopoulos, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2053-2053
Open Access | Times Cited: 319
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research
Mohammad Waseem, Bi‐Dar Wang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1093-1093
Open Access | Times Cited: 9
Patient-Derived Tumor Xenograft Models: Toward the Establishment of Precision Cancer Medicine
Taichiro Goto
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 64-64
Open Access | Times Cited: 47
Exploring the Wnt Pathway as a Therapeutic Target for Prostate Cancer
Sarah Koushyar, Valérie S. Méniel, Toby J. Phesse, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 309-309
Open Access | Times Cited: 26
The roles of patient‐derived xenograft models and artificial intelligence toward precision medicine
Venkatachalababu Janitri, K.N. ArulJothi, Vijay Murali Ravi Mythili, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 6
miRNAs and androgen deprivation therapy for prostate cancer
Maria Konoshenko, Olga E. Bryzgunova, Pavel P. Laktionov
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188625-188625
Closed Access | Times Cited: 29
Preclinical In Vivo Animal Xenograft Models: Heterogeneity and Biomarkers of Therapeutic Response and Resistance
Mohamed Y. Zaky, Nahed S. Lamloum, Noha A. Ahmed, et al.
(2025), pp. 109-127
Closed Access
Development and Characterization of a Spontaneously Metastatic Patient-Derived Xenograft Model of Human Prostate Cancer
Tobias Lange, Su Jung Oh‐Hohenhorst, Simon A. Joosse, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 23
IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation
Yipeng Xu, Gabriela Páchniková, He Wang, et al.
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 12
Pre-Clinical Models to Study Human Prostate Cancer
Martin K. Thomsen, Morten Busk
Cancers (2023) Vol. 15, Iss. 17, pp. 4212-4212
Open Access | Times Cited: 7
Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)
Jessica Cao, Wing Hei Chan, Moses Chow
International Journal of Oncology (2022) Vol. 60, Iss. 5
Open Access | Times Cited: 11
A thorough understanding of the role of lncRNA in prostate cancer pathogenesis; Current knowledge and future research directions
Ramin Haghighi, Roxana Yolanda Castillo-Acobo, Ali H. Amin, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154666-154666
Closed Access | Times Cited: 6
Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations
Amber N. Habowski, Deepthi Poornima Budagavi, Sandra D. Scherer, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 565-565
Open Access | Times Cited: 2
Advances in neuroendocrine prostate cancer research: From model construction to molecular network analyses
Xue Shui, Rong Xu, Caiqin Zhang, et al.
Laboratory Investigation (2021) Vol. 102, Iss. 4, pp. 332-340
Open Access | Times Cited: 13
Conditional reprogramming: Modeling urological cancer and translation to clinics
Wei Liu, Lingao Ju, Songtao Cheng, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 2
Open Access | Times Cited: 12
New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
Vittoria Rago, Anna Perri, Silvia Di Agostino
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2743-2743
Open Access | Times Cited: 4
Focus on organoids: cooperation and interconnection with extracellular vesicles – Is this the future of in vitro modeling?
Ancuța Jurj, Sergiu Pașca, Cornelia Braicu, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 367-381
Open Access | Times Cited: 10
High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice
Riikka Huhtaniemi, Petra Sipilä, Arttu Junnila, et al.
iScience (2022) Vol. 25, Iss. 5, pp. 104287-104287
Open Access | Times Cited: 7
An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors
Naz Chaudary, Ellis Wiljer, Warren D. Foltz, et al.
The Prostate (2024) Vol. 84, Iss. 9, pp. 823-831
Open Access | Times Cited: 1
Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [18F]DCFPyL PET Imaging
Jyoti Roy, Margaret White, Falguni Basuli, et al.
Molecular Imaging and Biology (2021) Vol. 23, Iss. 5, pp. 745-755
Open Access | Times Cited: 9
Pre-Clinical Models to Study Human Prostate Cancer
Martin K. Thomsen, Morten Busk
(2023)
Open Access | Times Cited: 3
Personalized Medicine in Oncology
Ari M. Vanderwalde
MDPI eBooks (2022)
Open Access | Times Cited: 4
An overview of the latest in state-of-the-art murine models for prostate cancer
Elisabete Nascimento-Gonçalves, Fernanda Seixas, Rita Ferreira, et al.
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 11, pp. 1349-1364
Closed Access | Times Cited: 4
Small Mitochondria-Targeting Fluorophore with Multifunctional Therapeutic Activities against Prostate Cancer via the HIF1α/OATPs Pathway
Jing Qin, Caiqin Zhang, Yong Zhao, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 12, pp. 6226-6236
Open Access
Page 1 - Next Page

Scroll to top